This Government Contract opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Manufacturing of Bupivacaine/Epinephrine Injection

Closed

Federal

Submission Closed05/26/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

METOPROLOL TARTRATEThe contract pertains to the procurement of Metoprolol Tartrate, identified by the National Stock Number 6505-01-615-1537, with a requested quantity of one unit under purchase request number 7017142424. The solicitation, numbered SPE2DP-26-T-3815, was posted by the Defense Logistics Agency, a branch of the Department of Defense, on June 16, 2026. The deadline for responses to this solicitation is June 22, 2026, indicating a brief window for bid submissions. This contract is categorized as a solicitation from a federal agency, with no specified type of set-aside or NAICS code provided. The place of performance and office location details are unspecified beyond being within the United States. The solicitation is accessible through the Defense Logistics Agency’s bidding system, and it appears focused on securing this specific pharmaceutical item for defense-related use.

Defense Logistics Agency

POSTED

DEADLINE

Supply of QIAamp Viral RNA Mini KitsThe contract involves the supply of eight kits specifically designed for viral RNA extraction from clinical samples, identified as QIAamp Viral RNA Mini Kits. Issued by the U.S. Embassy in Tbilisi under the Department of State, this subcontract is categorized under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The procurement process was initiated on June 16, 2026, with a response deadline set for July 6, 2026. The performance location for delivery is in Tbilisi, with a designated postal code of 0186. This contracting opportunity does not specify a solicitation number, type of set-aside, or further details on organization type or points of contact. It is a straightforward supply contract aimed at equipping the designated facility in Tbilisi with essential kits for viral RNA extraction, which are critical for clinical diagnostics and research related to viral pathogens. The contract is accessible through a dedicated link on the federal contracting platform, indicating transparency and open competition in the procurement process.

POSTED

DEADLINE

Wound Infection Prevention & Sepsis Countermeasure DevelopmentThe contract involves the development of a drug/device combination product aimed at preventing or treating wound infections and sepsis specifically in battlefield or austere environments. The project is targeted to advance this product to Phase I clinical trials under the FDA 505(b)(2) regulatory pathway, which facilitates the approval process by leveraging existing data. This effort is intended to address critical medical needs encountered by military personnel in challenging settings, ensuring rapid and effective countermeasures against potentially life-threatening infections. Issued by the Army Medical Resources Acquisition Activity under the Department of Defense, the contract is a subcontract with a focus on the pharmaceutical manufacturing sector (NAICS code 325412). The work will be performed in Frederick, capturing the strategic importance of this location for medical research and development. The solicitation was posted on June 16, 2026, with a response deadline of July 17, 2026, highlighting a clear and concise timeline for interested parties. This project underscores a high-priority initiative to enhance battlefield medical capabilities through innovative therapeutic solutions.

Army Medical Resources Acq Activity

POSTED

DEADLINE

Supply of Diagnostic PCR Kits (Zika, Dengue, Chikungunya)This contract involves the supply of one kit of the VIASURE Real-Time PCR Kit designed for the simultaneous detection of Zika, Dengue, and Chikungunya viruses. The contract is a subcontract opportunity posted by the US Embassy in Tbilisi under the Department of State. The solicitation was made public on June 16, 2026, with a response deadline set for July 6, 2026. The contract falls under the NAICS code 325412, indicating it pertains to pharmaceutical preparation manufacturing. The kit is intended for use in Tbilisi, Georgia, and aims to facilitate efficient diagnostic testing for these three viruses in a single assay. This opportunity does not specify any set-aside requirements, and detailed contact information is not provided. The purpose is to enhance diagnostic capabilities in the region through timely and reliable detection of these mosquito-borne illnesses.

POSTED

DEADLINE

Supply of COPAN UTM RT 3ML Collection SystemsThe contract involves the supply of 300 packets of COPAN UTM RT 3ML collection systems without applicators, intended for specimen collection and transport. This procurement is structured as a subcontract and falls under the NAICS code 325412, indicating its classification within pharmaceutical preparation manufacturing. The contract is issued by the US Embassy in Tbilisi, specifically through the Department of State, with the place of performance set in Tbilisi. The solicitation was posted on June 16, 2026, with a response deadline of July 6, 2026. While there is no designated type of set-aside or specific organization type required for bidders, the procurement is focused on acquiring bulk specimen collection systems without applicators, reflecting a specialized medical supply need. The contract details emphasize timely delivery to the designated location, ensuring the availability of these collection systems for relevant health and research activities overseen by the embassy.

US Embassy Tbilisi

POSTED

2 days ago

DEADLINE

in 19 days

AI Contract Overview

The contract involves the production of Bupivacaine Hydrochloride 0.5% combined with Epinephrine 0.005 mg/ml, formulated in 1.8 mL cartridges. The manufacturing process must adhere strictly to FDA Good Manufacturing Practices (GMP) as well as specific military medical standards, ensuring the product meets both civilian regulatory requirements and the unique specifications necessary for military use. This pharmaceutical manufacturing subcontract is managed under the Department of Defense’s Medical Supply Chain Pharmacy FSA, highlighting its strategic importance for military medical readiness. The solicitation was posted on May 18, 2026, with a response deadline set for May 26, 2026. The contract falls under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The place of performance is listed as FPO, with the associated ZIP code 96662, indicating a likely overseas or military postal facility. The contract does not specify any set-aside provisions or detailed organizational types but is focused on subcontracting opportunities within the pharmaceutical production sector to fulfill medical supply needs for defense-related operations.

General Info

Manufacture Bupivacaine with Epinephrine under FDA and military standards for Department of Defense.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

FPO, AP, 96662, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 18

subcontract

Response DeadlineMay 26

Deadline has passed

Submission Closed

05/26/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressN/A

ContactsNo contact information available

Full Description

Manufacture of Bupivacaine Hydrochloride 0.5% and Epinephrine 0.005 mg/ml in 1.8 mL cartridges, compliant with FDA GMP and military medical specifications.